Recombinant Human CCL25/TECK Protein, CF 9046-TK-025/CF from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Human CCL25/TECK Protein, CF
CompanyR&D Systems, a Bio-Techne Brand
Price $303.00Supplier Page View Company Product Page
Catalog Number9046-TK-025/CF
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution
FormatLyophilized from a 0.2 µm filtered solution in Acetonitrile and TFA
NCBI Gene AliasesTECKvar, SCYA25, TECK, Ck beta-15, Ckb15
NCBI Full Gene NameC-C motif chemokine ligand 25
Source/Expression SystemE. coli-derived Recombinant Human CCL25/TECK Protein, CF
Molecule NameCCL25/TECK
SpeciesHuman
Molecular WeightObserved: 14 kDa, reducing conditions
Theoretical: 14 kDa
Purity>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining
Conjugate/TagUnconjugated
ApplicationsBioactivity
Size25 ug

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(1) CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma via the PI3K/AKT signaling pathwayPeerJJanuary 1, 2022Chai S, Wen Z, Zhang R, Bai Y, Liu J, Li J, Kongling W, Chen W, Wang F, Gao L.progression. Materials and Methods Chemicals and antibodies The main reagents involved in this study were CCL25 (#9046-TK-025/CF; R&D Systems Inc., Minneapolis, MN, USA), CCR9 inhibitor (Vercirnon, #GSK-1605786; MedchenExpress, Monmouth

(3) RARα/RXR synergism potentiates retinoid responsiveness in cutaneous T-cell lymphoma cell linesExperimental dermatologyNovember 1, 2017Wang L, DeMarco SS, Peaks MS, Maiorana-Boutilier AL, Chen J, Crouch MJ, Shewchuk BM, Shaikh SR, Phillips CM, Bridges LC.

Recombinant Human CCL25/TECK Protein, CF